Compounds / Anabolic / Methyldrostanolone

Methyldrostanolone

Methyldrostanolone (Superdrol — 17α-Methylated DHT Derivative)

AnabolicFDA: Not approved — never approved any...WADA: PROHIBITED — Category S1

Overview

⚠ NO HUMAN CLINICAL TRIALS. Never FDA-approved. Briefly sold as an OTC 'prohormone' supplement 2005–2006 before DEA scheduling. Multiple published case reports of severe hepatotoxicity including liver failure requiring transplant. No therapeutic benefit established in any human study.

Mechanism of Action

2α,17α-dimethyl-5α-androstan-17β-ol-3-one. DHT derivative with 17α-methylation for oral bioavailability and 2α-methylation for enhanced anabolic activity. Does not aromatize. High anabolic:androgenic ratio on paper. Notably hepatotoxic — multiple case reports of severe cholestatic hepatitis and liver failure.

Molecular Profile

Molecular weight

334.5 Da

CAS number

3381-88-2

Key Research Findings

No human trials; no FDA approval; severe hepatotoxicity case reports; liver failure cases; never approved any indication.

Published Research

Am J Gastroenterol (2006)

Jasiurkowski B et al. Cholestatic jaundice and IgA nephropathy induced by OTC muscle building agent superdrol

View source

Related Anabolic Compounds

Testosterone Cypionate Testosterone Enanthate Testosterone Propionate Testosterone Suspension Sustanon (Testosterone Blend)Nandrolone Decanoate

Clinical Guidance

Research data is not a treatment plan. If you are considering Methyldrostanolone, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.

Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.

Running Methyldrostanolone? Log doses and track your cycle.

Interactive tools for this compound:

Reconstitution calculator · Full deep dive · Peptide fundamentals